newsfilter
← Latest News
PR Newswire·

Did Kyverna Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

  • Halper Sadeh LLC is investigating whether Kyverna Therapeutics, Inc. officers & directors breached fiduciary duties to shareholders.
  • The investigation focuses on NASDAQ-listed Kyverna Therapeutics (KYTX).
  • Shareholders may seek corporate governance reforms, fund recovery, court-approved incentive awards, or other relief.
  • Legal services are offered on a contingent fee basis with no out-of-pocket costs or obligations for investors.
  • Shareholders are urged to contact the firm immediately due to potential time limits on enforcing rights.
  • Investor participation aims to improve company policies, oversight, & transparency to enhance shareholder value.
  • Daniel Sadeh & Zachary Halper are the attorneys handling the matter.
  • Contact can be made via phone at (212) 763-0060 or email at sadeh@halpersadeh.com or zhalper@halpersadeh.com.
  • The firm's office is located at One World Trade Center, 85th Floor, New York, NY 10007.
  • This announcement is an attorney advertisement dated October 22, 2026.